{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
USAN:OPEMALIRSEN SODIUM [USAN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:zorevunersen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:marpinersen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02476019: Phase 2 Interventional Completed Obesity
(2015)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04526730: Phase 2 Interventional Active, not recruiting Melanoma
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:tomligisiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:umedaptanib pegol [INN]
Source URL:
Class:
NUCLEIC ACID